Fabio Cataldi
Chief Tech/Sci/R&D Officer en LANDOS BIOPHARMA, INC. .
Fortuna: - $ al 31/03/2024
Perfil
Fabio Cataldi is currently the Chief Medical Officer & Executive Vice President at Landos Biopharma, Inc. He previously worked as the Senior Director-Gastroenterology Biotherapeutics at Pfizer Inc. from 2010 to 2015.
He also held the position of Vice President & Head-Gastroenterology at Arena Pharmaceuticals, Inc. Additionally, he served as the VP-Clinical Development in Internal Medicine at Shire Japan KK from 2015 to 2017.
Dr. Cataldi obtained a doctorate degree from the University of Campania Luigi Vanvitelli.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
LANDOS BIOPHARMA, INC.
-.--% | 31/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Fabio Cataldi
| Empresas | Cargo | Inicio |
|---|---|---|
| LANDOS BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 05/09/2022 |
Antiguos cargos conocidos de Fabio Cataldi.
| Empresas | Cargo | Fin |
|---|---|---|
Shire Japan KK
 Shire Japan KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Japan KK is a Japanese pharmaceutical company that manufactures pharmaceuticals. The private company is based in Tokyo, Japan. | Corporate Officer/Principal | 01/07/2017 |
| PFIZER, INC. | Corporate Officer/Principal | 01/07/2015 |
| ARENA PHARMACEUTICALS | Corporate Officer/Principal | - |
Formación de Fabio Cataldi.
| University of Campania Luigi Vanvitelli | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| LANDOS BIOPHARMA, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
Shire Japan KK
Shire Japan KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Japan KK is a Japanese pharmaceutical company that manufactures pharmaceuticals. The private company is based in Tokyo, Japan. | Health Technology |
- Bolsa de valores
- Insiders
- Fabio Cataldi
